 | • レポートコード：20QY06-04967 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、癌用治療薬のグローバル市場について種類別（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他）、用途別（血液癌、乳癌、消化器癌、前立腺癌、呼吸器・肺癌、その他の癌）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・癌用治療薬市場の概要 ・世界の主要地域別癌用治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の癌用治療薬市場規模2015-2026：種類別（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他） ・世界の癌用治療薬市場規模2015-2026：用途別（血液癌、乳癌、消化器癌、前立腺癌、呼吸器・肺癌、その他の癌） ・癌用治療薬の北米市場規模2015-2020 ・癌用治療薬のヨーロッパ市場規模2015-2020 ・癌用治療薬の中国市場規模2015-2020 ・癌用治療薬の日本市場規模2015-2020 ・癌用治療薬の東南アジア市場規模2015-2020 ・癌用治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、、Novartis、、Celgene、、Bristol-Myers Squibb、、Amgen、、Johnson & Johnson、、Pfizer、、Takeda、、Eli Lilly、、AstraZeneca、、Astellas、、Merck & Co.、、Sanofi、、Bayer、、Biogen Idec、、Eisai、、Teva、、Otsuka、、Merck KGaA、、Ipsen、、AbbVie、、Gilead Sciences、） ・癌用治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・癌用治療薬の市場動向・機会・課題 ・調査の結論 |
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
Market Analysis and Insights: Global Cancer Treatment Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cancer Treatment Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cancer Treatment Drugs industry.
Based on our recent survey, we have several different scenarios about the Cancer Treatment Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 150870 million in 2019. The market size of Cancer Treatment Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Cancer Treatment Drugs Scope and Market Size
The global Cancer Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Treatment Drugs market is segmented into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segment by Application, the Cancer Treatment Drugs market is segmented into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
The Cancer Treatment Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Cancer Treatment Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Treatment Drugs Market Share Analysis
Cancer Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Treatment Drugs business, the date to enter into the Cancer Treatment Drugs market, Cancer Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
レポート目次1 Cancer Treatment Drugs Market Overview
1.1 Cancer Treatment Drugs Product Scope
1.2 Cancer Treatment Drugs Segment by Type
1.2.1 Global Cancer Treatment Drugs Sales by Type (2020-2026)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Treatment Drugs Segment by Application
1.3.1 Global Cancer Treatment Drugs Sales Comparison by Application (2020-2026)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Cancer Treatment Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cancer Treatment Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Cancer Treatment Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Cancer Treatment Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Cancer Treatment Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Cancer Treatment Drugs Industry
1.5.1.1 Cancer Treatment Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cancer Treatment Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cancer Treatment Drugs Players to Combat Covid-19 Impact
2 Cancer Treatment Drugs Estimate and Forecast by Region
2.1 Global Cancer Treatment Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cancer Treatment Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cancer Treatment Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Cancer Treatment Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Cancer Treatment Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cancer Treatment Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cancer Treatment Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cancer Treatment Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Cancer Treatment Drugs Estimates and Projections (2015-2026)
2.4.3 China Cancer Treatment Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Cancer Treatment Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cancer Treatment Drugs Estimates and Projections (2015-2026)
2.4.6 India Cancer Treatment Drugs Estimates and Projections (2015-2026)
3 Global Cancer Treatment Drugs Competition Landscape by Players
3.1 Global Top Cancer Treatment Drugs Players by Sales (2015-2020)
3.2 Global Top Cancer Treatment Drugs Players by Revenue (2015-2020)
3.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2019)
3.4 Global Cancer Treatment Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Cancer Treatment Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cancer Treatment Drugs Players (Opinion Leaders)
4 Global Cancer Treatment Drugs Market Size by Type
4.1 Global Cancer Treatment Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Cancer Treatment Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Cancer Treatment Drugs Price by Type (2014-2020)
4.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cancer Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Cancer Treatment Drugs Price Forecast by Type (2021-2026)
5 Global Cancer Treatment Drugs Market Size by Application
5.1 Global Cancer Treatment Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Cancer Treatment Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Cancer Treatment Drugs Price by Application (2015-2020)
5.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cancer Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Treatment Drugs Price Forecast by Application (2021-2026)
3 North America Cancer Treatment Drugs Market Facts & Figures
3.2 North America Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
3.3 North America Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
3.4 North America Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
4 Europe Cancer Treatment Drugs Market Facts & Figures
4.2 Europe Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
5 China Cancer Treatment Drugs Market Facts & Figures
5.2 China Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
5.3 China Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
5.4 China Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
6 Japan Cancer Treatment Drugs Market Facts & Figures
6.2 Japan Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Cancer Treatment Drugs Market Facts & Figures
7.2 Southeast Asia Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
8 India Cancer Treatment Drugs Market Facts & Figures
8.2 India Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
8.3 India Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
8.4 India Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cancer Treatment Drugs Business
12.1 Roche
12.1.1 Roche Cancer Treatment Drugs Corporation Information
12.1.2 Roche Cancer Treatment Drugs Business Overview and Total Revenue
12.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Cancer Treatment Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Cancer Treatment Drugs Corporation Information
12.2.2 Novartis Cancer Treatment Drugs Business Overview and Total Revenue
12.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Cancer Treatment Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Cancer Treatment Drugs Corporation Information
12.3.2 Celgene Cancer Treatment Drugs Business Overview and Total Revenue
12.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celgene Cancer Treatment Drugs Products Offered
12.3.5 Celgene Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Cancer Treatment Drugs Corporation Information
12.4.2 Bristol-Myers Squibb Cancer Treatment Drugs Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Amgen
12.5.1 Amgen Cancer Treatment Drugs Corporation Information
12.5.2 Amgen Cancer Treatment Drugs Business Overview and Total Revenue
12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Cancer Treatment Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Cancer Treatment Drugs Corporation Information
12.6.2 Johnson & Johnson Cancer Treatment Drugs Business Overview and Total Revenue
12.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Pfizer
12.7.1 Pfizer Cancer Treatment Drugs Corporation Information
12.7.2 Pfizer Cancer Treatment Drugs Business Overview and Total Revenue
12.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Cancer Treatment Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Takeda
12.8.1 Takeda Cancer Treatment Drugs Corporation Information
12.8.2 Takeda Cancer Treatment Drugs Business Overview and Total Revenue
12.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Takeda Cancer Treatment Drugs Products Offered
12.8.5 Takeda Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Cancer Treatment Drugs Corporation Information
12.9.2 Eli Lilly Cancer Treatment Drugs Business Overview and Total Revenue
12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
12.9.5 Eli Lilly Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Cancer Treatment Drugs Corporation Information
12.10.2 AstraZeneca Cancer Treatment Drugs Business Overview and Total Revenue
12.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Astellas
12.11.1 Astellas Cancer Treatment Drugs Corporation Information
12.11.2 Astellas Cancer Treatment Drugs Business Overview and Total Revenue
12.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Astellas Cancer Treatment Drugs Products Offered
12.11.5 Astellas Recent Development
12.12 Merck & Co.
12.12.1 Merck & Co. Cancer Treatment Drugs Corporation Information
12.12.2 Merck & Co. Cancer Treatment Drugs Business Overview and Total Revenue
12.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merck & Co. Cancer Treatment Drugs Products Offered
12.12.5 Merck & Co. Recent Development
12.13 Sanofi
12.13.1 Sanofi Cancer Treatment Drugs Corporation Information
12.13.2 Sanofi Cancer Treatment Drugs Business Overview and Total Revenue
12.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sanofi Cancer Treatment Drugs Products Offered
12.13.5 Sanofi Recent Development
12.14 Bayer
12.14.1 Bayer Cancer Treatment Drugs Corporation Information
12.14.2 Bayer Cancer Treatment Drugs Business Overview and Total Revenue
12.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Bayer Cancer Treatment Drugs Products Offered
12.14.5 Bayer Recent Development
12.15 Biogen Idec
12.15.1 Biogen Idec Cancer Treatment Drugs Corporation Information
12.15.2 Biogen Idec Cancer Treatment Drugs Business Overview and Total Revenue
12.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Biogen Idec Cancer Treatment Drugs Products Offered
12.15.5 Biogen Idec Recent Development
12.16 Eisai
12.16.1 Eisai Cancer Treatment Drugs Corporation Information
12.16.2 Eisai Cancer Treatment Drugs Business Overview and Total Revenue
12.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Eisai Cancer Treatment Drugs Products Offered
12.16.5 Eisai Recent Development
12.17 Teva
12.17.1 Teva Cancer Treatment Drugs Corporation Information
12.17.2 Teva Cancer Treatment Drugs Business Overview and Total Revenue
12.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Teva Cancer Treatment Drugs Products Offered
12.17.5 Teva Recent Development
12.18 Otsuka
12.18.1 Otsuka Cancer Treatment Drugs Corporation Information
12.18.2 Otsuka Cancer Treatment Drugs Business Overview and Total Revenue
12.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Otsuka Cancer Treatment Drugs Products Offered
12.18.5 Otsuka Recent Development
12.19 Merck KGaA
12.19.1 Merck KGaA Cancer Treatment Drugs Corporation Information
12.19.2 Merck KGaA Cancer Treatment Drugs Business Overview and Total Revenue
12.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Merck KGaA Cancer Treatment Drugs Products Offered
12.19.5 Merck KGaA Recent Development
12.20 Ipsen
12.20.1 Ipsen Cancer Treatment Drugs Corporation Information
12.20.2 Ipsen Cancer Treatment Drugs Business Overview and Total Revenue
12.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Ipsen Cancer Treatment Drugs Products Offered
12.20.5 Ipsen Recent Development
12.21 AbbVie
12.21.1 AbbVie Cancer Treatment Drugs Corporation Information
12.21.2 AbbVie Cancer Treatment Drugs Business Overview and Total Revenue
12.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.21.4 AbbVie Cancer Treatment Drugs Products Offered
12.21.5 AbbVie Recent Development
12.22 Gilead Sciences
12.22.1 Gilead Sciences Cancer Treatment Drugs Corporation Information
12.22.2 Gilead Sciences Cancer Treatment Drugs Business Overview and Total Revenue
12.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Gilead Sciences Cancer Treatment Drugs Products Offered
12.22.5 Gilead Sciences Recent Development
13 Cancer Treatment Drugs Manufacturing Cost Analysis
13.1 Cancer Treatment Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Treatment Drugs
13.4 Cancer Treatment Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Treatment Drugs Distributors List
14.3 Cancer Treatment Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesTable 1. Global Cancer Treatment Drugs Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Cancer Treatment Drugs Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Cancer Treatment Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Cancer Treatment Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Cancer Treatment Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Cancer Treatment Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Cancer Treatment Drugs Sales (K Pcs) by Region (2015-2020)
Table 10. Global Cancer Treatment Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Cancer Treatment Drugs Revenue Share by Region (2015-2020)
Table 13. Global Cancer Treatment Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 14. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Cancer Treatment Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Cancer Treatment Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Cancer Treatment Drugs (K Pcs) of Key Companies (2015-2020)
Table 18. Global Cancer Treatment Drugs Sales Share by Company (2015-2020)
Table 19. Global Cancer Treatment Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Cancer Treatment Drugs Revenue Share by Company (2015-2020)
Table 21. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2019)
Table 22. Global Cancer Treatment Drugs Average Price (USD/Pcs) of Key Company (2015-2020)
Table 23. Manufacturers Cancer Treatment Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Cancer Treatment Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Cancer Treatment Drugs Players
Table 27. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 28. Global Cancer Treatment Drugs Sales Share by Type (2015-2020)
Table 29. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Cancer Treatment Drugs Price (K Pcs) by Type (2015-2020)
Table 31. Global Cancer Treatment Drugs Sales Share by Type (2021-2026)
Table 32. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Cancer Treatment Drugs Revenue Share by Type (2021-2026)
Table 34. Global Cancer Treatment Drugs Price (K Pcs) by Type (2021-2026)
Table 35. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 36. Global Cancer Treatment Drugs Sales Share by Application (2015-2020)
Table 37. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Cancer Treatment Drugs Price (K Pcs) by Application (2015-2020)
Table 39. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2021-2026)
Table 40. Global Cancer Treatment Drugs Sales Share by Application (2021-2026)
Table 41. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Cancer Treatment Drugs Revenue Share by Application (2021-2026)
Table 43. Global Cancer Treatment Drugs Price (K Pcs) by Application (2021-2026)
Table 44. United States Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 45. United States Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 47. United States Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 49. United States Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 51. Europe Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 53. Europe Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 55. Europe Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 56. China Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 57. China Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 58. China Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 59. China Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 60. China Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 61. China Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 63. Japan Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 65. Japan Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 67. Japan Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 69. Southeast Asia Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 71. Southeast Asia Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 73. Southeast Asia Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 74. India Cancer Treatment Drugs Sales (K Pcs) by Company (2015-2020)
Table 75. India Cancer Treatment Drugs Sales Market Share by Company (2015-2020)
Table 76. India Cancer Treatment Drugs Sales (K Pcs) by Type (2015-2020)
Table 77. India Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 78. India Cancer Treatment Drugs Sales (K Pcs) by Application (2015-2020)
Table 79. India Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Roche Cancer Treatment Drugs Product
Table 84. Roche Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Novartis Cancer Treatment Drugs Product
Table 89. Novartis Recent Development
Table 90. Celgene Corporation Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Celgene Cancer Treatment Drugs Product
Table 94. Celgene Recent Development
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Cancer Treatment Drugs Product
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Amgen Cancer Treatment Drugs Product
Table 104. Amgen Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Cancer Treatment Drugs Product
Table 109. Johnson & Johnson Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Pfizer Cancer Treatment Drugs Product
Table 114. Pfizer Recent Development
Table 115. Takeda Corporation Information
Table 116. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Takeda Description and Business Overview
Table 118. Takeda Cancer Treatment Drugs Product
Table 119. Takeda Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Eli Lilly Description and Business Overview
Table 123. Eli Lilly Cancer Treatment Drugs Product
Table 124. Eli Lilly Recent Development
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. AstraZeneca Cancer Treatment Drugs Product
Table 129. AstraZeneca Recent Development
Table 130. Astellas Corporation Information
Table 131. Astellas Description and Business Overview
Table 132. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Astellas Cancer Treatment Drugs Product
Table 134. Astellas Recent Development
Table 135. Merck & Co. Corporation Information
Table 136. Merck & Co. Description and Business Overview
Table 137. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Merck & Co. Cancer Treatment Drugs Product
Table 139. Merck & Co. Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Sanofi Cancer Treatment Drugs Product
Table 144. Sanofi Recent Development
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Business Overview
Table 147. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Bayer Cancer Treatment Drugs Product
Table 149. Bayer Recent Development
Table 150. Biogen Idec Corporation Information
Table 151. Biogen Idec Description and Business Overview
Table 152. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Biogen Idec Cancer Treatment Drugs Product
Table 154. Biogen Idec Recent Development
Table 155. Eisai Corporation Information
Table 156. Eisai Description and Business Overview
Table 157. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Eisai Cancer Treatment Drugs Product
Table 159. Eisai Recent Development
Table 160. Teva Corporation Information
Table 161. Teva Description and Business Overview
Table 162. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Teva Cancer Treatment Drugs Product
Table 164. Teva Recent Development
Table 165. Otsuka Corporation Information
Table 166. Otsuka Description and Business Overview
Table 167. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 168. Otsuka Cancer Treatment Drugs Product
Table 169. Otsuka Recent Development
Table 170. Merck KGaA Corporation Information
Table 171. Merck KGaA Description and Business Overview
Table 172. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 173. Merck KGaA Cancer Treatment Drugs Product
Table 174. Merck KGaA Recent Development
Table 175. Ipsen Corporation Information
Table 176. Ipsen Description and Business Overview
Table 177. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 178. Ipsen Cancer Treatment Drugs Product
Table 179. Ipsen Recent Development
Table 180. AbbVie Corporation Information
Table 181. AbbVie Description and Business Overview
Table 182. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 183. AbbVie Cancer Treatment Drugs Product
Table 184. AbbVie Recent Development
Table . Gilead Sciences Corporation Information
Table . Gilead Sciences Description and Business Overview
Table . Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table . Gilead Sciences Cancer Treatment Drugs Product
Table . Gilead Sciences Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Cancer Treatment Drugs Distributors List
Table 193. Cancer Treatment Drugs Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Treatment Drugs Product Picture
Figure 2. Global Cancer Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cancer Treatment Drugs Market Share by Application in 2020 & 2026
Figure 6. Blood Cancer Examples
Figure 7. Breast Cancer Examples
Figure 8. Gastrointestinal Cancer Examples
Figure 9. Prostate Cancer Examples
Figure 10. Respiratory/Lung Cancer Examples
Figure 11. Other Cancers Examples
Figure 12. Global Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 13. Global Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Cancer Treatment Drugs Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 15. Global Cancer Treatment Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Cancer Treatment Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 19. Europe Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Cancer Treatment Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Cancer Treatment Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Cancer Treatment Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Cancer Treatment Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Cancer Treatment Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Cancer Treatment Drugs Players Market Share by Revenue in Cancer Treatment Drugs 2015 & 2019
Figure 30. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Figure 32. Global Cancer Treatment Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Cancer Treatment Drugs Revenue Share by Application (2015-2020)
Figure 34. Global Cancer Treatment Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 36. United States Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 37. Europe Cancer Treatment Drugs Sales Market Share by Company in 2019
Figure 38. Europe Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 39. Europe Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 40. China Cancer Treatment Drugs Sales Market Share by Company in 2019
Figure 41. China Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 42. China Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 43. Japan Cancer Treatment Drugs Sales Market Share by Company in 2019
Figure 44. Japan Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 45. Japan Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 46. Southeast Asia Cancer Treatment Drugs Sales Market Share by Company in 2019
Figure 47. Southeast Asia Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 48. Southeast Asia Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 49. India Cancer Treatment Drugs Sales Market Share by Company in 2019
Figure 50. India Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 51. India Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Key Raw Materials Price Trend
Figure 75. Manufacturing Cost Structure of Cancer Treatment Drugs
Figure 76. Manufacturing Process Analysis of Cancer Treatment Drugs
Figure 77. Cancer Treatment Drugs Industrial Chain Analysis
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Porter's Five Forces Analysis
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…- 尿路上皮がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Urothelial Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1565.9 million by 2025, from USD 980.1 million in 2019. The Urothelial C…
- 頭頸部がん治療薬/治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …
- 消化器がんデバイスの世界市場レポート2020 Gastrointestinal cancer is the malignant condition that affects the gastrointestinal tract and the digestive system. This includes cancers of the liver, small intestine, esophagus, gall bladder, pancreas, anus, stomach, and bowel. Market Analysis and Insights: Global Gastrointestinal Cancer Devices …
- 前立腺がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Cancer Tre…